<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144583">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01862185</url>
  </required_header>
  <id_info>
    <org_study_id>AB-PCTQ1</org_study_id>
    <nct_id>NCT01862185</nct_id>
  </id_info>
  <brief_title>The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic Patients</brief_title>
  <official_title>Pengaruh Pemeriksaan Procalcitonin Semikuantitatif Terhadap Adekuasi Terapi Antibiotik Empirik Awal Dan Mortalitas Pada Pasien Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <authority>Indonesia: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sepsis is a serious clinical condition with a considerable morbidity and mortality.
      Procalcitonin (PCT) is a good biomarker for early diagnosis and infection monitoring. The
      present study aimed to investigate the effect of semi-quantitative PCT test to the empirical
      antibiotic initiation time, the appropriateness of empirical antibiotics and mortality in
      septic patients.

      The hypothesis of the study are :

        -  There is an effect on mortality between septic patients who do and do not do
           semi-quantitative PCT examination

        -  There is an effect on empirical antibiotic initiation time between septic patients who
           do and do not do semi-quantitative PCT examination

        -  There is an effect on appropriateness of empirical antibiotic between septic patients
           who do and do not do semi-quantitative PCT examination

      Study design is randomized diagnostic trial which is also a pragmatic trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>mortality rate</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>mortality in 14 days since the patients were included in this study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the timing of empirical antibiotic first dose</measure>
    <time_frame>in 24 hours since the patient was diagnosis as sepsis</time_frame>
    <safety_issue>No</safety_issue>
    <description>when does the patient get their first dose of empirical antibiotic in 24 hours since the patient was diagnosis as sepsis?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the appropriateness of empirical antibiotic</measure>
    <time_frame>in 24 hours since the patient was diagnosed as sepsis</time_frame>
    <safety_issue>No</safety_issue>
    <description>does the empirical antibiotic that given in 24 hours since the patient was diagnosis as sepsis is effective?</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">205</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>semi-quantitative procalcitonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients whom checked semi-quantitative procalcitonin examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients whom do not checked semi-quantitative procalcitonin examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>semi-quantitative procalcitonin</intervention_name>
    <arm_group_label>semi-quantitative procalcitonin</arm_group_label>
    <other_name>PCT-Q</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged more than 18 years old

          -  have at least two concomitant systemic inflammatory response syndrome criteria

          -  have focal infection

          -  with or without sign of organ hypoperfusion or dysfunction

        Exclusion Criteria:

          -  post operative patient

          -  trauma patient

          -  have obtained prior antibiotic

          -  refused to participate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Dharaniyadewi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Indonesia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 6, 2014</lastchanged_date>
  <firstreceived_date>May 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Dana Dharaniyadewi</investigator_full_name>
    <investigator_title>student</investigator_title>
  </responsible_party>
  <keyword>semiquantitative</keyword>
  <keyword>procalcitonin</keyword>
  <keyword>sepsis</keyword>
  <keyword>antibiotics</keyword>
  <keyword>mortality</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
